Cyclovirobuxine D is refined alkaloid extracted from boxwood and monomeric compound developed from traditional Chinese drug. It is effective drug to cure coronary heart disease and angina. Oral taking Cyclovirobuxine D is mostly used for mild and moderate patients, and injection solution is for acute and severe ones.
Cyclovirobuxine D Injection Solution Project of our company has been listed into the Key Technical Innovation Items of Anhui Province. Our company is the first clinic researcher and producer of Cyclovirobuxine D. Our research has been approved by State Food Administration, and has entered to clinic experiment stage.
Anhui Wanbei Pharmaceutical Co., Ltd. is located in Suzhou, Anhui. Our company was founded in 1988, originally a state-owned company, and was privatized later. We specialize in the manufacture of API and finished drug products such as tablets, granules, capsules and parenteral solutions. Our company has a total assets of RMB120 million and occupies a total area of 200, 000 square meters, including 100, 000 square meters of GMP compliant facility area.
